159 related articles for article (PubMed ID: 16199478)
1. Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo.
Ha T; Hua F; Li Y; Ma J; Gao X; Kelley J; Zhao A; Haddad GE; Williams DL; Browder IW; Kao RL; Li C
Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H985-94. PubMed ID: 16199478
[TBL] [Abstract][Full Text] [Related]
2. [Role of MyD88-dependent nuclear factor-kappaB signaling pathway in the development of cardiac hypertrophy in vivo].
Li YH; Ha TZ; Chen Q; Li CF
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(4):267-72. PubMed ID: 15854490
[TBL] [Abstract][Full Text] [Related]
3. Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload.
Ha T; Li Y; Hua F; Ma J; Gao X; Kelley J; Zhao A; Haddad GE; Williams DL; William Browder I; Kao RL; Li C
Cardiovasc Res; 2005 Nov; 68(2):224-34. PubMed ID: 15967420
[TBL] [Abstract][Full Text] [Related]
4. Blocking the MyD88-dependent pathway protects the myocardium from ischemia/reperfusion injury in rat hearts.
Hua F; Ha T; Ma J; Gao X; Kelley J; Williams DL; Browder IW; Kao RL; Li C
Biochem Biophys Res Commun; 2005 Dec; 338(2):1118-25. PubMed ID: 16259957
[TBL] [Abstract][Full Text] [Related]
5. MyD88-dependent nuclear factor-kappaB activation is involved in fibrinogen-induced hypertrophic response of cardiomyocytes.
Li T; Wang Y; Liu C; Hu Y; Wu M; Li J; Guo L; Chen L; Chen Q; Ha T; Li C; Li Y
J Hypertens; 2009 May; 27(5):1084-93. PubMed ID: 19342961
[TBL] [Abstract][Full Text] [Related]
6. EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats.
Sheng R; Gu ZL; Xie ML; Zhou WX; Guo CY
Acta Pharmacol Sin; 2007 Feb; 28(2):191-201. PubMed ID: 17241521
[TBL] [Abstract][Full Text] [Related]
7. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling.
Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y
Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832
[TBL] [Abstract][Full Text] [Related]
8. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.
Okada K; Minamino T; Tsukamoto Y; Liao Y; Tsukamoto O; Takashima S; Hirata A; Fujita M; Nagamachi Y; Nakatani T; Yutani C; Ozawa K; Ogawa S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):705-12. PubMed ID: 15289376
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload.
Hedhli N; Lizano P; Hong C; Fritzky LF; Dhar SK; Liu H; Tian Y; Gao S; Madura K; Vatner SF; Depre C
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1385-93. PubMed ID: 18676687
[TBL] [Abstract][Full Text] [Related]
10.
Cao YY; Li K; Li Y; Tian XT; Ba HX; Wang A; Li XH
Pharm Biol; 2020 Dec; 58(1):176-183. PubMed ID: 33826488
[TBL] [Abstract][Full Text] [Related]
11. Maslinic acid protects against pressure overload-induced cardiac hypertrophy in mice.
Liu YL; Kong CY; Song P; Zhou H; Zhao XS; Tang QZ
J Pharmacol Sci; 2018 Oct; 138(2):116-122. PubMed ID: 30389277
[TBL] [Abstract][Full Text] [Related]
12. Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling.
Hu LW; Benvenuti LA; Liberti EA; Carneiro-Ramos MS; Barreto-Chaves ML
Am J Physiol Regul Integr Comp Physiol; 2003 Dec; 285(6):R1473-80. PubMed ID: 12933361
[TBL] [Abstract][Full Text] [Related]
13. Puerarin attenuates pressure overload-induced cardiac hypertrophy.
Yuan Y; Zong J; Zhou H; Bian ZY; Deng W; Dai J; Gan HW; Yang Z; Li H; Tang QZ
J Cardiol; 2014 Jan; 63(1):73-81. PubMed ID: 23906530
[TBL] [Abstract][Full Text] [Related]
14. Effect of matrine and carvedilol on collagen and MMPs activity of hypertrophy myocardium induced by pressure overload.
Zhang YJ; Xiang MX; San J; Cheng G; Wang SS
J Zhejiang Univ Sci B; 2006 Mar; 7(3):245-50. PubMed ID: 16502514
[TBL] [Abstract][Full Text] [Related]
15. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling.
Singla DK; Lyons GE; Kamp TJ
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1308-14. PubMed ID: 17416601
[TBL] [Abstract][Full Text] [Related]
16. Adapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts.
Kumbar DH; VanBergen A; Ocampo C; Muangmingsuk S; Griffin AJ; Gupta M
J Appl Physiol (1985); 2007 May; 102(5):2024-32. PubMed ID: 17255372
[TBL] [Abstract][Full Text] [Related]
17. Myocyte apoptosis occurs early during the development of pressure-overload hypertrophy in infant myocardium.
Choi YH; Cowan DB; Moran AM; Colan SD; Stamm C; Takeuchi K; Friehs I; del Nido PJ; McGowan FX
J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1356-62, 1362.e1-3. PubMed ID: 19464448
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rd contributes the attenuation of cardiac hypertrophy in vivo and in vitro.
Zhang N; An X; Lang P; Wang F; Xie Y
Biomed Pharmacother; 2019 Jan; 109():1016-1023. PubMed ID: 30551351
[TBL] [Abstract][Full Text] [Related]
20. Expression of Wnt and NCX1 and its correlation with cardiomyocyte apoptosis in mouse with myocardial hypertrophy.
He J; Cai Y; Luo LM; Wang R
Asian Pac J Trop Med; 2015 Nov; 8(11):930-936. PubMed ID: 26614993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
